Pharmaceutical Manufacturing, Vaccines and White Paper

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

JUNE 20, 2025

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. Credit: Department of Health Abu Dhabi.

Vaccines

Vaccines Pharmaceutical Manufacturing Communication Hospitals

Madrigal poised to enter European MASH market after CHMP endorsement

Pharmaceutical Technology

JUNE 20, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Communication Hospitals Packaging

NSW government invests $13.39m in life-changing therapies

Pharmaceutical Technology

JUNE 20, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Insurance Coverage and Processing

Insurance Coverage and Processing Hospitals Communication Pharmaceutical Manufacturing

Podcast: The benefits of blockchain in healthcare

Pharmaceutical Technology

JUNE 20, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Medical Records Drug Development Vaccines

Novartis’ ribociclib approved in Canada for early breast cancer

Pharmaceutical Technology

JUNE 20, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Communication Hospitals Packaging

London Biotechnology Show 2025: Novo Nordisk harnesses AI/ML to accelerate drug development landscape

Pharmaceutical Technology

JUNE 20, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Drug Development

Drug Development Pharmaceutical Manufacturing Communication Hospitals

‘Right shoring’ API production in Europe

Pharmaceutical Technology

MARCH 22, 2023

“The European Commission plans to launch its revised EU pharmaceutical package in Q1 2023 to ease drug shortages,” she says. Among other things, supply chain optimisation, maintaining access to affordable vaccines, and supporting innovation for unmet clinical needs will be the discussion topics, she adds.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Packaging Communication Diabetes

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

FEBRUARY 15, 2023

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised. Cold chain shipments are particularly vulnerable.

Vaccines

Vaccines Pharmaceutical Manufacturing Communication

FDA cell and gene therapy director exit increases ‘volatility’ for sector

Pharmaceutical Technology

JUNE 20, 2025

Unlike vaccines, the agency leaders see the modality as a path to prevent and cure disease – aligning with the current administration’s wider national health strategy. Cell and gene therapy safety sadly hit the news for another reason this week, when Sarepta’s Elevidys (delandistrogene moxeparvovec) was linked to a second patient death.

Insurance Coverage and Processing

Insurance Coverage and Processing Communication Pharmaceutical Manufacturing Packaging

Trump’s push to onshore pharma manufacturing clouded by ‘lack of clarity’

Pharmaceutical Technology

JUNE 11, 2025

Robert Barrie June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Drugmakers have poured billions of dollars into pharma manufacturing facilities across the US as they adapt to macroeconomic pressures. Conversely, foreign manufacturing plants will be subject to increased inspection fees.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Communication Hospitals Packaging

Pharmacist Digest

DoH – Abu Dhabi and Sanofi link for vaccine development

Madrigal poised to enter European MASH market after CHMP endorsement

Trending Sources

NSW government invests $13.39m in life-changing therapies

Podcast: The benefits of blockchain in healthcare

Novartis’ ribociclib approved in Canada for early breast cancer

London Biotechnology Show 2025: Novo Nordisk harnesses AI/ML to accelerate drug development landscape

‘Right shoring’ API production in Europe

Using big data to stabilise pharma supply chains in an age of disruption

FDA cell and gene therapy director exit increases ‘volatility’ for sector

Trump’s push to onshore pharma manufacturing clouded by ‘lack of clarity’

Stay Connected